A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

The anti‐cancer gene, E1A, can be complexed to a lipid carrier, DC‐Cholesterol:DOPE, to form tgDCC‐E1A, which can be injected directly into tumors.

[1]  M. Hung,et al.  Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo , 1998, Oncogene.

[2]  M. Hung,et al.  Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A , 1997, Oncogene.

[3]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Frisch,et al.  E1a induces the expression of epithelial characteristics , 1994, The Journal of cell biology.

[5]  I. Tannock,et al.  A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer , 2000, Nature Medicine.

[6]  Joe Y. Chang,et al.  The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer* , 1997, Oncogene.

[7]  Z. Estrov,et al.  E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  K. Somasundaram,et al.  Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Hung,et al.  Inhibition of Nuclear Factor-κB Activity Is Involved in E1A-mediated Sensitization of Radiation-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[10]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[11]  M. Hung,et al.  Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene , 1991, Molecular and cellular biology.

[12]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[13]  M. C. Hu,et al.  E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. , 1999, The Journal of biological chemistry.

[14]  S. Ramón y. Cajal,et al.  Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene. , 1996, Oncogene.

[15]  S. Frisch,et al.  Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. , 1990, Oncogene.

[16]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer treatment and research.

[17]  M. Hung,et al.  Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. , 1995, Oncogene.

[18]  S. Frisch,et al.  Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. , 1995, Cancer research.

[19]  L. Huang,et al.  A novel cationic liposome reagent for efficient transfection of mammalian cells. , 1991, Biochemical and biophysical research communications.

[20]  R. Epand,et al.  Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. , 1992, Biochimica et biophysica acta.

[21]  M. Hung,et al.  E1A Sensitizes Cells to Tumor Necrosis Factor-induced Apoptosis through Inhibition of IκB Kinases and Nuclear Factor κB Activities* , 1999, The Journal of Biological Chemistry.

[22]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[23]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[24]  S. Y. Cajal,et al.  Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells , 1999, Cancer Gene Therapy.

[25]  T. Reynolds,et al.  Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[27]  M. Hung,et al.  Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. , 1997, The Journal of biological chemistry.